Le Lézard
Classified in: Health, Covid-19 virus
Subjects: TDS, ACC

Sectra's Year-end Report 2019/2020: Sectra Grows With Increased Profitability-operating Profit for the Year Increased 25.4%


LINKÖPING, Sweden, June 3, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reports the best earnings year in its history, exceeding its three financial goals. Our success and growth are built on high levels of customer satisfaction, long-standing customer relationships, high-quality products and skilled, dedicated employees. These conditions form a stable foundation for our future development and profitability. With a strong financial position, positive cash flow and significant recurring revenue, Sectra is well equipped to manage the great degree of uncertainty resulting from COVID-19. In light of this, it is proposed that the Annual General Meeting (AGM) resolve that SEK 4.50 per share be distributed to the shareholders through a share redemption program.

2019/2020 fiscal year            

Fourth quarter, February-April 2020            

Torbjörn Kronander, CEO and President Sectra AB, comments
"When our customers in the healthcare sector become more efficient in their daily work and can thus provide care for more people, or when society's vulnerability decreases through the use of our data security solutions, then we have also succeeded. It is deeply satisfying that our long-term efforts in creating real value for customers, patients and society at large have enabled us to report the best earnings year in Sectra's history."  

"Several of our projects are extensive, which leads to broad fluctuations between quarters since a significant portion of earnings is recognized in conjunction with services going online and project deliveries. Accordingly, it is important to look more at trends than at the output for an individual quarter when assessing our development. In the coming fiscal year we expect a weaker first quarter than normal and a sharp focus on deploying our services to customers during the second half of the year, particularly during the spring months. This is due in part to natural seasonal variations, when many customers want to come online before the relatively calm summer period, but also to delays in projects and orders because of COVID-19. Over the long term, our new subscription model for software licenses will enable more balance between quarters, but it is believed this will not have a major effect over the next few years."

"Our stable development and positive underlying cash flows and profitability give me every reason to remain optimistic. We have a number of exciting projects in the pipeline as well as completely new geographic markets that could eventually become significant. Our possibilities for growth are strong in all operating areas for the foreseeable future, even if COVID-19 will likely mean temporarily dampened demand in certain markets. With our work and investments in the field, and innovation that has the potential to increase customer value, we are creating value for our customers and are thus helping to make society healthier and safer. This customer value is the foundation of our success, and also determines how we successfully create shareholder value and returns for our owners.See the attached year-end report for further CEO comments and information."

Presentation of the interim report with in-depth information on the new subscription model 
Torbjörn Kronander, President and CEO of Sectra AB, and Mats Franzén, CFO of Sectra AB, will present the financial report and answer questions. Fredrik Gustavsson, CTO and Pre-Sales/Product Marketing Manager at Sectra Imaging IT Solutions AB, will present Sectra's new subscription model for software licenses. The presentation will be held in English.

When: Time: June 3, 2020, at 10:00 am
Follow live or listen to the recording afterward: investor.sectra.com/q4report1920
SE: +46850558366
UK: +443333009035
US: +18335268397 

This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. (CET) on June 3, 2020.

For further information, please contact:
Dr. Torbjörn Kronander
President and CEO
Sectra AB
+46-(0)-705-23-52-27 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/sectra-s-year-end-report-2019-2020--sectra-grows-with-increased-profitability-operating-profit-for-t,c3126542

The following files are available for download:

https://mb.cision.com/Main/1263/3126542/1258216.pdf

Sectra's year-end report 2019/2020

https://news.cision.com/sectra/i/torbjorn-kronander,c2792425

Torbjörn Kronander

https://news.cision.com/sectra/i/sectra-digital-pathology,c2792433

Sectra Digital Pathology

https://news.cision.com/sectra/i/sectra-secure-mobile-workplace,c2792426

Sectra secure mobile workplace

 

SOURCE Sectra


These press releases may also interest you

at 02:00
Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region and a team of experienced life science investors, Eir Ventures will invest in innovative...

at 01:19
Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is...

at 01:00
MilliporeSigma today opened its M Labtm Collaboration Center in Shanghai, the company's largest of nine centers worldwide....

at 01:00
Merck, a leading science and technology company, opened its M Labtm Collaboration Center in Shanghai, the company's largest of nine centers...

9 jui 2020
Carromex, a mathematical research-based innovation company based in Australia, unveiled a new cloud-based pharmaceutical software platform called Pharma Leads https://carromex.com/products/pharma-leads/, that is set to significantly contribute to the...

9 jui 2020
Award-winning actress and producer, American Institute for Stuttering Board Member, and longtime supporter, Emily Blunt hosted the 14th annual American Institute for Stuttering's (AIS) Benefit Gala, which went virtual this year due to the Covid-19...



News published on 3 june 2020 at 02:34 and distributed by: